---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-108078"
form_type: "8-K"
ticker: "CARM"
cik: "0001485003"
company_name: "Carisma Therapeutics Inc."
filed_at: "2024-10-11T23:59:59+00:00"
generated_at: "2026-05-30T15:20:12.288368+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Carisma Therapeutics receives Nasdaq deficiency notice for market value below $50M

## Summary
- Nasdaq notified Carisma on Oct 10, 2024 that MVLS fell below $50M minimum requirement.
- Company has 180 days, until April 8, 2025, to regain compliance by closing at $50M+ for 10 consecutive days.
- Failure to regain compliance may lead to delisting; company can appeal to a Nasdaq Hearing Panel.
- Carisma will monitor MVLS and evaluate options to meet Nasdaq listing standards.

## SEC filing metadata
- accession: 0001104659-24-108078
- form_type: 8-K
- ticker: CARM
- cik: 0001485003
- company_name: Carisma Therapeutics Inc.
- filed_at: 2024-10-11T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1485003/000110465924108078/0001104659-24-108078-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1485003/000110465924108078/tm2426043d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-108078
- JSON: https://secwatch.observer/filing/0001104659-24-108078.json
- Plain text: https://secwatch.observer/filing/0001104659-24-108078.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.